INS and atrial fibrillation: To date, no data are available on the prognostic role of the various diabetes statuses (diabetes on insulin vs diabetes not on insulin vs no diabetes) on clinical outcome in the setting of real-world clinical practice related to AF patients receiving non-vitamin K antagonist anticoagulants (NOACs).